Stock listing

BMV:COR Cencora, Inc. Acciones

Mexican listing (BMV) of Cencora, Inc. · home listing NYSE:COR

Follow Cencora, Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:COR

$339.09 USD -9.22 (-2.6%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:COR

Past year -6.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$337.88 – $348.57 USDNov 20, 2026
Volume
1.23M sharesNov 20, 2026
Market cap
$64.71B USDAt the close on Nov 20, 2026 · price × 190.8M shares outstanding
52-week range
$244.82 – $377.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$417.5M USDMedian day 1.11M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Cencora, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:COR · Home$339.09 USD-9.22 (-2.6%)1,231,459$344.31$348.57$337.88$348.31Close on Nov 20, 2026
LSE:0HF3$348.60 USD-2.77 (-0.8%)30$348.50$351.89$344.72$351.37Close on Nov 18, 2026
B3:C1CO34775.73 BRL0.00 (0.0%)—775.73775.73775.73775.73Close on Nov 19, 2026
Frankfurt:ABG€307.30 EUR-7.40 (-2.4%)—€307.30€307.30€307.30€314.70Close on Nov 20, 2026
Dusseldorf:ABG€311.00 EUR+0.70 (+0.2%)—€310.50€312.60€310.50€310.30Close on Nov 20, 2026
Munich:ABG€311.35 EUR-7.90 (-2.5%)—€311.35€311.35€311.35€319.25Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:COR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$339.09-9.22-2.6%$344.31$348.57$337.881,231,459
$348.31-2.25-0.6%$347.16$349.80$344.491,204,991
$350.56-6.38-1.8%$353.05$357.28$349.701,250,560
$356.94-2.09-0.6%$362.59$363.31$355.901,029,380
$359.03+9.65+2.8%$351.12$359.39$350.111,358,586
$349.38-0.50-0.1%$352.95$354.84$348.68997,506
$349.88+1.17+0.3%$345.67$350.17$345.35845,428
$348.71+2.95+0.9%$347.00$350.17$342.601,071,188
$345.76+12.20+3.7%$338.58$347.41$336.551,942,671
$333.56-6.12-1.8%$333.61$338.54$333.051,584,010
$339.68-14.32-4.0%$359.87$363.95$337.552,441,785
$354.00+13.50+4.0%$342.20$355.64$336.722,887,379
$340.50+2.66+0.8%$335.90$342.09$334.311,647,541
$337.84+7.00+2.1%$333.26$338.16$329.151,506,754
$330.84+0.31+0.1%$336.79$340.19$330.201,347,640
$330.53+6.18+1.9%$328.84$331.07$326.341,025,200
$324.35-1.02-0.3%$321.82$327.43$320.061,076,700
$325.37-4.63-1.4%$327.77$330.15$325.001,123,100
$330.00-1.00-0.3%$331.60$335.45$329.17993,500
$331.00-7.48-2.2%$337.15$338.07$330.311,168,300
$338.48-1.95-0.6%$344.43$344.43$337.111,183,200
$340.43-2.84-0.8%$343.05$344.44$338.341,514,600
$343.27+3.27+1.0%$343.50$345.00$339.53916,800
$340.00-0.92-0.3%$338.13$342.18$336.471,031,400
$340.92-0.49-0.1%$343.31$343.31$339.011,978,900
$341.41+5.24+1.6%$342.70$345.46$339.261,589,600
$336.17+6.06+1.8%$332.08$336.33$330.821,187,000
$330.11+5.05+1.6%$328.07$331.60$327.111,113,800
$325.06+1.21+0.4%$325.37$327.96$323.64959,200
$323.85+2.50+0.8%$319.50$325.82$318.79781,900
$321.35+4.10+1.3%$316.59$322.58$314.90897,578
$317.25+0.88+0.3%$317.30$322.41$315.151,060,756
$316.37+1.44+0.5%$314.63$316.44$311.83817,905
$314.93+5.88+1.9%$309.43$316.06$307.871,148,053
$309.05-0.73-0.2%$308.29$310.43$302.141,164,367
$309.78+9.53+3.2%$303.18$313.02$300.771,889,580
$300.25-7.35-2.4%$306.40$306.40$295.011,811,105
$307.60+3.79+1.2%$300.00$307.62$298.211,268,388
$303.81-3.11-1.0%$306.20$307.94$302.841,521,363
$306.92-2.95-1.0%$308.95$310.89$304.311,084,057
$309.87-2.41-0.8%$313.32$316.61$309.181,081,436
$312.28-2.15-0.7%$315.51$320.24$310.711,103,059
$314.43-2.06-0.7%$317.62$320.00$313.89775,721
$316.49+7.71+2.5%$309.74$316.98$308.511,049,948
$308.78-0.63-0.2%$307.42$311.81$304.453,344,625
$309.41-9.09-2.9%$318.36$319.77$309.241,098,496
$318.50-4.79-1.5%$321.83$323.98$317.97931,141
$323.29-2.94-0.9%$324.98$325.88$318.08913,496
$326.23+4.66+1.4%$325.64$327.79$322.461,063,973
$321.57+0.62+0.2%$323.99$325.13$317.96844,056
$320.95-2.37-0.7%$326.34$327.90$320.911,346,332
$323.32-1.37-0.4%$322.24$326.99$321.921,215,502
$324.69-6.26-1.9%$327.55$330.00$323.052,200,493
$330.95-6.27-1.9%$333.48$336.01$330.201,027,638
$337.22+0.86+0.3%$337.90$338.71$334.871,085,311
$336.36+5.39+1.6%$330.62$337.91$330.621,398,344
$330.97+7.37+2.3%$325.97$331.65$325.921,518,597
$323.60+1.57+0.5%$321.11$326.57$319.041,387,962
$322.03+0.80+0.2%$322.30$323.74$320.39628,857
$321.23-6.56-2.0%$324.35$324.68$320.471,074,792
$327.79-0.27-0.1%$328.39$331.00$326.30841,574
$328.06+4.29+1.3%$322.68$328.51$321.431,114,917
$323.77+5.73+1.8%$317.76$324.58$317.65760,395
$318.04+3.35+1.1%$314.74$320.21$313.13905,404
$314.69-2.41-0.8%$314.77$318.23$312.611,175,755

Splits

3 splits since 1999 · NYSE:COR · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
2-for-1Split
2-for-1Split
Ticker
BMV:COR
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
BMV
Currency
MXN

What changed lately

Latest news

All Cencora, Inc. news

Cencora, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
34 in the last 12 months · 52 in all · newest Nov 4, 2026 · oldest 2025
Calls
50 calls with a replay · 50 with a transcript · latest Nov 4, 2026
Decks
61 decks · latest Nov 4, 2026

Where Cencora, Inc. is listed

ListingExchangeCountryCurrency
NYSE:COR · Home listingNYSEUnited StatesUSD
gettex:ABGgettexGermanyEUR
Tradegate:ABGTradegateGermanyEUR
VIE:ABCViennaAustriaEUR
LS Exchange:766149LS ExchangeGermanyEUR
Lang & Schwarz:766149Lang & SchwarzGermanyEUR
LSE:0HF3LSEUnited KingdomUSD
BMV:COR · This pageBMVMexicoMXN
BOATS:CORBOATSUnited StatesUSD
Milan:1CORMilanItalyEUR
B3:C1CO34B3BrazilBRL
BIVA:CORBIVAMexicoMXN
Frankfurt:ABGFrankfurtGermanyEUR
Stuttgart:ABGStuttgartGermanyEUR
Dusseldorf:ABGDusseldorfGermanyEUR
Munich:ABGMunichGermanyEUR
BX Swiss:ABGBX SwissSwitzerlandCHF
Hamburg:ABGHamburgGermanyEUR
Hanover:ABGHanoverGermanyEUR
Xetra:ABGXetraGermanyEUR

Valuation

P/E 24.6× against a median of 25.7×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$73.62B USD
P/E
24.6×
EV/sales
0.2×
EV/EBITDA
18.0×
Price/book
21.2×
Gross margin
4.0%
Operating margin
0.9%
Net margin
0.8%
Debt to equity
3.8×
Beta vs S&P 500
0.12

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Cencora, Inc. · NYSE:CORUS$64.71BUS$73.62B24.6×0.2×18.0×21.2×0.8%3.8×0.12
McKesson Corporation · NYSE:MCKUS$123.5BUS$126.2B26.3×0.3×18.0×n/a1.1%n/a-0.11
HCA Healthcare, Inc. · NYSE:HCAUS$99.34BUS$148.9B14.7×1.9×n/an/a8.6%n/a0.23
Cardinal Health, Inc. · NYSE:CAHUS$63.17BUS$59.79B34.8×0.2×16.3×n/a0.7%n/a0.04
Labcorp Holdings Inc. · NYSE:LHUS$29.81BUS$35.40B29.7×2.4×n/a3.4×6.9%0.7×0.33
Quest Diagnostics Incorporated · NYSE:DGXUS$28.42BUS$33.17B25.2×2.8×14.4×3.7×9.5%0.7×-0.03
Tenet Healthcare Corporation · NYSE:THCUS$21.19BUS$18.68B7.3×0.8×3.0×3.9×13.1%0.0×0.60
IHH Healthcare Bhd. · MYX:IHHUS$16.98BUS$20.21B31.1×3.1×14.6×2.2×8.4%0.5×n/a
Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSPUS$14.28BUS$14.90B59.0×5.0×22.8×12.5×8.1%0.8×n/a
Encompass Health Corporation · NYSE:EHCUS$13.19BUS$13.16B20.5×2.1×n/a4.9×10.2%0.0×0.03
Rede D'Or Sao Luiz SA · BMFBOVESPA:RDOR3US$13.12BUS$14.96B16.9×1.5×6.2×3.6×7.9%2.5×n/a
Median of the othersUS$24.80BUS$26.69B25.7×2.0×14.6×3.7×8.2%0.7×0.04

Forecasts

7 strong buy · 3 buy · 4 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
388.25 USD · Analysts' mean
EPS, year to Sep 2027
19.64 · 9 analysts
Revenue, year to Sep 2027
351.8B · 8 analysts

Team and board

Officers

OfficerRole
Robert P. MauchPresident and Chief Executive Officer
Eva BorattoExecutive Vice President and Chief Financial Officer
Matt GlucksmannSVP and President, Health Systems
Richard TremonteEVP and President, Global Specialty Pharmaceuticals and Operations
Tim CernohousSenior Vice President and President, Retail Pharmacy and Alternate Care
Elizabeth CampbellExecutive Vice President and Chief Legal Officer
Melissa O'BrienVice President, Investor Relations
François MandevilleExecutive Vice President and Chief Strategy and M&A Officer
Juan GuerraExecutive Vice President, Alliance Healthcare
Pawan VermaExecutive Vice President and Chief Data and Information Officer
Sam HammockExecutive Vice President and Chief Human Resources Officer

Board

DirectorRole
Robert E. SanchezDirector

Events

Calls

CallWhenStatus
Cencora (NYSE:COR) Q4 2026 Earnings CallWed, Nov 04, 2026 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2026 Earnings CallWed, Aug 05, 2026 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2026 Earnings CallWed, May 06, 2026 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2026 Earnings CallWed, Feb 04, 2026 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2025 Earnings CallWed, Nov 05, 2025 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2025 Earnings CallWed, Aug 06, 2025 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2025 Earnings CallWed, May 07, 2025 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2025 Earnings CallWed, Feb 05, 2025 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2024 Earnings CallWed, Nov 06, 2024 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2024 Earnings CallWed, Jul 31, 2024 · 8:30 AM ETReplay
All 50 calls
CallWhenStatus
Cencora (NYSE:COR) Q2 2024 Earnings CallWed, May 01, 2024 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2024 Earnings CallWed, Jan 31, 2024 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2023 Earnings CallThu, Nov 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2023 Earnings CallThu, Nov 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2023 Earnings CallWed, Aug 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2023 Earnings CallWed, Aug 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2023 Earnings CallTue, May 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2023 Earnings CallTue, May 02, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2023 Earnings CallWed, Feb 01, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2023 Earnings CallWed, Feb 01, 2023 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2022 Earnings CallThu, Nov 03, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2022 Earnings CallThu, Nov 03, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2022 Earnings CallWed, Aug 03, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2022 Earnings CallWed, Aug 03, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2022 Earnings CallWed, May 04, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2022 Earnings CallWed, May 04, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2022 Earnings CallWed, Feb 02, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2022 Earnings CallWed, Feb 02, 2022 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2021 Earnings CallThu, Nov 04, 2021 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2021 Earnings CallThu, Oct 28, 2021 · 12:00 PM ETReplay
Cencora (NYSE:COR) Q3 2021 Earnings CallWed, Aug 04, 2021 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2021 Earnings CallThu, Jul 29, 2021 · 12:00 PM ETReplay
Cencora (NYSE:COR) Q2 2021 Earnings CallWed, May 05, 2021 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2021 Earnings CallThu, Apr 29, 2021 · 12:00 PM ETReplay
Cencora (NYSE:COR) Q4 2020 Earnings CallThu, Feb 04, 2021 · 1:00 PM ETReplay
Cencora (NYSE:COR) Q1 2020 Earnings CallSat, Jan 30, 2021 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2020 Earnings CallThu, Nov 05, 2020 · 8:00 AM ETReplay
Cencora (NYSE:COR) Q3 2020 Earnings CallThu, Oct 29, 2020 · 12:00 PM ETReplay
Cencora (NYSE:COR) Q3 2020 Earnings CallWed, Aug 05, 2020 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2020 Earnings CallThu, May 07, 2020 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2020 Earnings CallThu, May 07, 2020 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2020 Earnings CallThu, Jan 30, 2020 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2019 Earnings CallThu, Nov 07, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q4 2019 Earnings CallWed, Nov 06, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2019 Earnings CallThu, Aug 01, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q3 2019 Earnings CallThu, Aug 01, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2019 Earnings CallThu, May 02, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q2 2019 Earnings CallThu, May 02, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2019 Earnings CallThu, Jan 31, 2019 · 8:30 AM ETReplay
Cencora (NYSE:COR) Q1 2019 Earnings CallThu, Jan 31, 2019 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 4, 2026 · Before open+4.0%
Q3 2026Aug 5, 2026 · Before open+3.6%
Q2 2026May 6, 2026 · Before open−17.4%
Q1 2026Feb 4, 2026 · Before open−8.8%
Q4 2025Nov 5, 2025 · Before open+2.8%
Q3 2025Aug 6, 2025 · Before open−2.9%
Q2 2025May 7, 2025 · Before open+4.7%
Q1 2025Feb 5, 2025 · Before open+0.7%
Q4 2024Nov 6, 2024+5.9%
Q3 2024Jul 31, 2024 · Before open+3.0%
All 20 quarters
QuarterResultsShare move
Q2 2024May 1, 2024 · Before open−4.1%
Q1 2024Jan 31, 2024 · Before open+5.5%
Q4 2023Nov 2, 2023 · Before open+2.6%
Q3 2023Aug 2, 2023 · Before open+1.2%
Q2 2023May 2, 2023 · Before open+1.4%
Q1 2023Feb 1, 2023 · Before open−4.7%
Q4 2022Nov 3, 2022 · Before open+2.0%
Q3 2022Aug 3, 2022 · Before open−2.7%
Q2 2022May 4, 2022 · Before open+4.0%
Q1 2022Feb 2, 2022 · Before open−1.1%

Open Events

Decks

DeckKindSlidesDate
Q4 2026 Earnings PresentationEarnings23 slidesNov 4, 2026
Q3 2026 Earnings PresentationEarnings18 slidesAug 5, 2026
Q2 2026 Earnings PresentationEarnings18 slidesMay 6, 2026
Q1 2026 Earnings PresentationEarnings20 slidesFeb 4, 2026
44th Annual J.P. Morgan Healthcare Conference (January 2026)Conference13 slidesJan 12, 2026
Q4 2025 Earnings PresentationEarnings24 slidesNov 5, 2025
Q3 2025 Earnings PresentationEarnings18 slidesAug 6, 2025
Q2 2025 Earnings PresentationEarnings18 slidesMay 7, 2025
Q1 2025 Earnings PresentationEarnings19 slidesFeb 5, 2025
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference15 slidesJan 13, 2025
Show 50 decks
DeckKindSlidesDate
Q4 2024 Earnings PresentationEarnings23 slidesNov 6, 2024
Q3 2024 Earnings PresentationEarnings19 slidesJul 31, 2024
Q2 2024 Earnings PresentationEarnings19 slidesMay 1, 2024
Q1 2024 Earnings PresentationEarnings19 slidesJan 31, 2024
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference18 slidesJan 8, 2024
Q4 2023 Earnings PresentationEarnings23 slidesNov 2, 2023
Q3 2023 Earnings PresentationEarnings18 slidesAug 2, 2023
Q2 2023 Earnings PresentationEarnings18 slidesMay 2, 2023
Q1 2023 Earnings PresentationEarnings18 slidesFeb 1, 2023
AmerisourceBergen — 41st Annual J.P. Morgan Healthcare Conference 2023Conference11 slidesJan 9, 2023
AmerisourceBergen — Q4 FY2022 Earnings PresentationEarnings21 slidesNov 3, 2022
AmerisourceBergen — Q3 FY2022 Earnings PresentationEarnings17 slidesAug 3, 2022
AmerisourceBergen — Investor Day (June 2022)Investor day65 slidesJun 1, 2022
AmerisourceBergen — Q2 2022 Earnings PresentationEarnings14 slidesMay 4, 2022
AmerisourceBergen — Q1 2022 Earnings PresentationEarnings14 slidesFeb 2, 2022
AmerisourceBergen — 40th Annual J.P. Morgan Healthcare Conference 2022Conference17 slidesJan 10, 2022
AmerisourceBergen — Q4 FY2021 Earnings PresentationEarnings18 slidesNov 4, 2021
AmerisourceBergen — Q3 FY2021 Earnings PresentationEarnings14 slidesAug 4, 2021
AmerisourceBergen — Q2 2021 Earnings PresentationEarnings14 slidesMay 5, 2021
AmerisourceBergen — Q1 FY2021 Earnings PresentationEarnings13 slidesFeb 4, 2021
AmerisourceBergen — 39th Annual J.P. Morgan Healthcare Conference (January 2021)Conference16 slidesJan 11, 2021
AmerisourceBergen — Merger or Acquisition (January 2021)Merger or acquisition12 slidesJan 8, 2021
AmerisourceBergen — Merger or Acquisition (January 2021)Merger or acquisition12 slidesJan 6, 2021
AmerisourceBergen — Q4 FY2020 Earnings PresentationEarnings17 slidesNov 5, 2020
AmerisourceBergen — Q3 FY2020 Earnings PresentationEarnings13 slidesAug 5, 2020
AmerisourceBergen — Q2 FY2020 Earnings PresentationEarnings13 slidesMay 7, 2020
AmerisourceBergen — Q1 FY2020 Earnings PresentationEarnings13 slidesJan 30, 2020
AmerisourceBergen — Q3 FY2019 Earnings PresentationEarnings13 slidesAug 1, 2019
AmerisourceBergen — Q2 FY2019 Earnings PresentationEarnings13 slidesMay 2, 2019
AmerisourceBergen — CECP CEO Investor Forum 2019Conference14 slidesFeb 25, 2019
AmerisourceBergen — Q1 FY2019 Earnings PresentationEarnings13 slidesJan 31, 2019
AmerisourceBergen — 37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference13 slidesJan 7, 2019
AmerisourceBergen — Q4 FY2018 Earnings PresentationEarnings17 slidesNov 6, 2018
AmerisourceBergen — Q3 FY2018 Earnings PresentationEarnings13 slidesAug 2, 2018
AmerisourceBergen — Q2 FY2018 Earnings PresentationEarnings13 slidesMay 2, 2018
AmerisourceBergen — Q1 FY2018 Earnings PresentationEarnings13 slidesFeb 6, 2018
AmerisourceBergen — Q4 FY2017 Earnings PresentationEarnings17 slidesNov 2, 2017
AmerisourceBergen — Q3 FY2017 Earnings PresentationEarnings14 slidesAug 3, 2017
AmerisourceBergen — Q2 FY2017 Earnings PresentationEarnings14 slidesMay 4, 2017
AmerisourceBergen — J.P. Morgan Healthcare Conference 2017Conference20 slidesJan 10, 2017

This page holds 50 of 61 decks. Open Decks

Open Decks

Financings

RaiseDate
Public offering of senior notes
Announced: Citigroup Global Markets Inc. +3
Dealers: Citigroup Global Markets Inc. (co-lead), J.P. Morgan Securities LLC (co-lead), BofA Securities, Inc. (co-lead), Wells Fargo Securities, LLC (co-lead)
Use of proceeds: Repay amounts under the 364-Day Term Credit Agreement used to fund part of the OneOncology acquisition; any remainder for general corporate purposes
Feb 10, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue321.3B294.0B262.2B238.6B214.0B189.9B179.6B167.9B153.1B146.8B
Cost of revenue309.9B284.0B253.2B230.3B207.0B184.7B174.5B163.3B148.6B142.6B
Gross profit11.5B9.91B8.96B8.30B6.94B5.19B5.14B4.61B4.55B4.27B
Selling, general and administrative6.49B5.66B5.31B4.85B3.59B2.77B2.66B2.46B2.13B2.09B
Operating income2.63B2.18B2.34B2.37B2.35B-5.14B1.11B1.44B1.06B1.53B
Depreciation and amortization1.05B1.09B963.9M693.9M505.2M391.1M462.4M465.1M397.6M364.7M
EBITDA3.68B3.27B3.30B3.06B2.86B-4.74B1.57B1.91B1.46B1.89B
Interest expense419.8M248.7M275.6M232.0M182.5M158.5M195.5M189.6M149.0M144.3M
Income before tax2.26B2.00B2.16B2.18B2.22B-5.29B967.1M1.18B917.9M1.39B
Income tax690.5M484.7M428.3M516.5M677.3M-1.89B113.0M-438.5M553.4M-37.0M
Net income1.55B1.51B1.75B1.70B1.54B-3.41B855.4M1.66B364.5M1.43B
Earnings per share, basic8.027.608.628.157.48-16.654.077.611.676.73
Earnings per share, diluted7.967.538.538.047.39-16.654.047.531.646.32

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.36B3.13B2.59B3.39B2.55B4.60B3.37B2.49B2.44B2.74B
Short-term investments0372.9M26.1M
Receivables25.2B23.9B20.9B18.5B18.2B13.8B12.4B11.3B10.3B9.18B
Inventory20.5B19.0B17.5B15.6B15.4B12.6B11.1B11.9B11.5B10.7B
Current assets52.2B47.7B42.8B39.6B38.8B33.1B28.1B25.9B24.3B22.9B
Property, plant and equipment2.54B2.18B2.14B2.14B2.16B1.48B1.77B1.89B1.80B1.53B
Goodwill13.7B9.32B9.57B8.50B9.03B6.71B6.71B6.66B6.04B5.99B
Total assets76.6B67.1B62.6B56.6B57.3B44.3B39.2B37.7B35.3B33.6B
Accounts payable54.7B50.9B45.8B40.2B38.0B31.7B28.4B26.8B25.4B23.9B
Current liabilities57.8B54.3B48.8B43.5B41.4B33.9B29.6B27.9B26.8B25.3B
Long-term debt7.54B3.81B4.15B4.63B6.38B3.62B4.03B4.16B3.43B3.58B
Total debt7.66B4.39B4.79B5.70B6.68B4.12B4.17B177.5M3.44B4.19B
Total liabilities74.8B66.3B61.9B56.5B56.8B45.1B36.5B35.0B33.3B31.5B
Shareholders' equity1.51B645.9M522.0M-211.6M223.4M-1.02B2.88B2.93B2.06B2.13B
Shares outstanding193.9M194.9M200.8M206.2M208.1M204.2M206.8M213.2M218.0M220.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations3.88B3.48B3.91B2.70B2.67B2.21B2.34B1.41B1.50B3.18B
Capital spending-668.0M-487.2M-458.4M-496.3M-438.2M-369.7M-310.2M-336.4M-466.4M-464.6M
Free cash flow3.21B3.00B3.45B2.21B2.23B1.84B2.03B1.07B1.04B2.71B
Cash from investing-4.98B-618.1M-2.60B-368.4M-6.14B-379.9M-375.8M-1.11B-498.0M-3.17B
Cash from financing2.25B-2.33B-2.22B-1.75B1.95B-603.6M-1.09B-242.9M-1.31B565.1M
Dividends paid-437.1M-416.2M-398.8M-391.7M-366.6M-343.6M-339.0M-333.0M-320.3M-288.5M
Share buybacks-435.5M-1.49B-1.18B-483.7M-82.2M-420.4M-674.0M-639.2M-329.9M-2.27B
Change in cash1.10B545.0M-840.6M523.4M-1.53B1.22B881.7M57.4M-306.7M574.4M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 10, 2026Insider tradeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
8-K · Current reportNov 4, 2026Current reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
8-K · Current reportOct 21, 2026ResultsSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 1, 2026Insider tradeSEC
8-K · Current reportSep 25, 2026Management or board changeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
144 · Notice of proposed saleSep 16, 2026Other filingsSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
144 · Notice of proposed saleSep 4, 2026Other filingsSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
144 · Notice of proposed saleAug 24, 2026Other filingsSEC
8-K · Current reportAug 14, 2026Management or board changeSEC
8-K · Current reportAug 12, 2026Current reportSEC
144 · Notice of proposed saleAug 6, 2026Other filingsSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026Material contractSEC
8-K · Current reportAug 5, 2026ResultsSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 30, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
11-K · Annual report of an employee planJun 18, 2026Annual reportSEC
8-K · Current reportJun 15, 2026Management or board changeSEC
8-K · Current reportMay 29, 2026Management or board changeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 23, 2026Current reportSEC
8-K · Current reportMar 17, 2026Management or board changeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
8-K · Current reportMar 6, 2026Meeting outcomeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 20, 2026Other filingsSEC
144 · Notice of proposed saleFeb 18, 2026Other filingsSEC
8-K · Current reportFeb 18, 2026Current reportSEC
8-K · Current reportFeb 13, 2026Material contractSEC
424B2 · ProspectusFeb 11, 2026Offer documentSEC
8-K · Current reportFeb 11, 2026Current reportSEC
FWP · Free writing prospectusFeb 10, 2026Offer documentSEC
424B5 · ProspectusFeb 10, 2026Offer documentSEC
8-K · Current reportFeb 10, 2026Current reportSEC
10-Q · Quarterly reportFeb 4, 2026Quarterly reportSEC
8-K · Current reportFeb 4, 2026ResultsSEC
3 · Initial statement of ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 22, 2026Insider tradeSEC
ARS · Annual report to shareholdersJan 22, 2026Annual reportSEC
DEFA14A · Additional proxy materialJan 22, 2026Meeting noticeSEC
DEF 14A · Proxy statementJan 22, 2026Meeting noticeSEC
8-K · Current reportJan 22, 2026Management or board changeSEC
144 · Notice of proposed saleJan 20, 2026Other filingsSEC
5 · Annual statement of ownershipJan 16, 2026Insider tradeSEC
8-K · Current reportJan 16, 2026Material contractSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 19, 2025Other filingsSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
144 · Notice of proposed saleDec 19, 2025Other filingsSEC
144 · Notice of proposed saleDec 18, 2025Other filingsSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
144 · Notice of proposed saleDec 17, 2025Other filingsSEC
8-K · Current reportDec 15, 2025Current reportSEC
10-K · Annual reportNov 25, 2025Annual reportSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipOct 21, 2025Insider tradeSEC
144 · Notice of proposed saleOct 21, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 3, 2025Insider tradeSEC
144 · Notice of proposed saleOct 1, 2025Other filingsSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 18, 2025Insider tradeSEC
144 · Notice of proposed saleSep 18, 2025Other filingsSEC
144 · Notice of proposed saleSep 16, 2025Other filingsSEC
8-K · Current reportSep 9, 2025Material contractSEC
8-K · Current reportSep 3, 2025Current reportSEC
8-K · Current reportAug 27, 2025Management or board changeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
144 · Notice of proposed saleAug 19, 2025Other filingsSEC
144 · Notice of proposed saleAug 18, 2025Other filingsSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2025Big-stake noticeSEC
4 · Change in ownershipJul 23, 2025Insider tradeSEC
4 · Change in ownershipJul 22, 2025Insider tradeSEC
144 · Notice of proposed saleJul 22, 2025Other filingsSEC
144 · Notice of proposed saleJul 18, 2025Other filingsSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
8-K · Current reportJul 3, 2025Material contractSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJun 25, 2025Insider tradeSEC
144 · Notice of proposed saleJun 24, 2025Other filingsSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
144 · Notice of proposed saleJun 18, 2025Other filingsSEC
144 · Notice of proposed saleJun 18, 2025Other filingsSEC
144 · Notice of proposed saleJun 18, 2025Other filingsSEC
11-K · Annual report of an employee planJun 17, 2025Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 9, 2025Big-stake noticeSEC
8-K · Current reportJun 6, 2025Material contractSEC
3 · Initial statement of ownershipJun 3, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
144 · Notice of proposed saleMay 29, 2025Other filingsSEC
8-K · Current reportMay 28, 2025Management or board changeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 28, 2025Big-stake noticeSEC
CERT · Exchange's certificate of listingMay 27, 2025Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeMay 22, 2025Other filingsSEC
8-K · Current reportMay 22, 2025Material contractSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
144 · Notice of proposed saleMay 20, 2025Other filingsSEC
8-K · Current reportMay 19, 2025Current reportSEC
424B2 · ProspectusMay 19, 2025Offer documentSEC
144 · Notice of proposed saleMay 19, 2025Other filingsSEC
144 · Notice of proposed saleMay 19, 2025Other filingsSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC

This page holds 200 of 1,009 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Cencora, Inc.’s releases · as of Jul 31, 2026

Common shares
190,827,165
Fully diluted
190,827,165

Fully diluted

LineSharesAs of
Common shares190,827,165Jul 31, 2026

Share count over time

CountShares
Jul 31, 2026190,827,165

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard23.6M12.4%US$7.09BSep 30, 2026
BlackRock18.2M9.6%US$5.47BSep 30, 2026
T. Rowe Price12.3M6.5%US$3.7BSep 30, 2026
State Street9.2M4.8%US$2.76BSep 30, 2026
Wellington8.5M4.5%US$2.55BSep 30, 2026
JPMorgan5.86M3.1%US$1.8BSep 30, 2026
Geode Capital5.43M2.8%US$1.62BSep 30, 2026
Boston Partners5.25M2.8%US$1.58BSep 30, 2026
Morgan Stanley3.86M2.0%US$1.16BSep 30, 2026
Bank of America3.71M1.9%US$1.11BSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
UBS3.3M1.7%US$991MSep 30, 2026
Fidelity3.13M1.6%US$941MSep 30, 2026
Goldman Sachs2M1.0%US$601MSep 30, 2026
Capital Group1.98M1.0%US$596MSep 30, 2026
Northern Trust1.96M1.0%US$587MSep 30, 2026
MUFG1.9M1.00%US$572MSep 30, 2026
Amundi1.72M0.90%US$516MSep 30, 2026
Invesco1.69M0.89%US$508MSep 30, 2026
Dimensional1.69M0.89%US$508MSep 30, 2026
Mawer Investment Management Ltd.1.38M0.72%US$413MSep 30, 2026
Nordea Investment Management AB1.36M0.71%US$414MSep 30, 2026
Citadel1.35M0.71%US$405MSep 30, 2026
Carmignac Gestion1.34M0.70%US$404MSep 30, 2026
Arrowstreet Capital, Limited Partnership1.32M0.69%US$396MSep 30, 2026
Bessemer Group Inc1.26M0.66%US$377MSep 30, 2026
Schwab1.25M0.66%US$377MSep 30, 2026
Legal & General1.19M0.62%US$358MSep 30, 2026
Wells Fargo1.19M0.62%US$357MSep 30, 2026
American Century1.17M0.61%US$351MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.1M0.53%US$302MSep 30, 2026
Manufacturers Life Insurance Company, The983K0.52%US$295MSep 30, 2026
BNY962K0.50%US$289MSep 30, 2026
Lazard Asset Management LLC954K0.50%US$286MSep 30, 2026
Raymond James Financial Inc918K0.48%US$276MSep 30, 2026
BMO906K0.47%US$272MSep 30, 2026
Neuberger Berman Group LLC887K0.46%US$267MSep 30, 2026
DWS811K0.43%US$244MSep 30, 2026
Millennium794K0.42%US$238MSep 30, 2026
HSBC775K0.41%US$233MSep 30, 2026
Nuveen762K0.40%US$229MSep 30, 2026
National Pension Service736K0.39%US$221MSep 30, 2026
Point72 Asset Management, L.P.659K0.35%US$198MSep 30, 2026
Beutel, Goodman & Co Ltd.658K0.34%US$198MSep 30, 2026
Qube Research & Technologies Ltd647K0.34%US$194MSep 30, 2026
Caisse de depot et placement du Quebec646K0.34%US$194MSep 30, 2026
AllianceBernstein631K0.33%US$189MSep 30, 2026
BNP Paribas605K0.32%US$182MSep 30, 2026
Sun Life580K0.30%US$174MSep 30, 2026
Franklin Templeton565K0.30%US$199MSep 30, 2026
Federated Hermes, Inc.536K0.28%US$161MSep 30, 2026

This page holds 50 of 1,353 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund5.87M3.1%US$1.66BJun 30, 2026
Vanguard 500 Index Fund5.04M2.6%US$1.43BJun 30, 2026
T. Rowe Price Capital Appreciation Fund4.44M2.3%US$1.26BJun 30, 2026
Vanguard Mid-Cap Index Fund4.01M2.1%US$1.13BJun 30, 2026
Vanguard Health Care Fund3.03M1.6%US$945MJul 31, 2026
iShares Core S&P 500 ETF2.68M1.4%US$757MJun 30, 2026
Fidelity 500 Index Fund2.49M1.3%US$671MMay 31, 2026
Vanguard Value Index Fund1.76M0.92%US$498MJun 30, 2026
Fidelity Magellan Fund1.55M0.81%US$440MJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF1.37M0.72%US$389MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
T. Rowe Price Value Fund, Inc.1.2M0.63%US$340MJun 30, 2026
Vanguard Mid-Cap Value Index Fund1.19M0.62%US$336MJun 30, 2026
Investment Co of America1.15M0.60%US$324MJun 30, 2026
iShares Russell Mid-Cap Growth ETF1.1M0.58%US$312MJun 30, 2026
Vanguard Dividend Appreciation Index Fund1.1M0.58%US$343MJul 31, 2026
Disciplined Value Mid Cap Fund1.08M0.57%US$306MJun 30, 2026
Vanguard Institutional Index Fund1.06M0.55%US$299MJun 30, 2026
JNL/T. Rowe Price Capital Appreciation Fund1.03M0.54%US$292MJun 30, 2026
iShares MSCI USA Min Vol Factor ETF946K0.50%US$295MJul 31, 2026
Disciplined Value Fund849K0.44%US$240MJun 30, 2026
Vanguard Windsor Fund806K0.42%US$251MJul 31, 2026
iShares Russell Mid-Cap ETF768K0.40%US$217MJun 30, 2026
JPMorgan Mid Cap Growth Fund750K0.39%US$212MJun 30, 2026
iShares Russell 1000 Growth ETF713K0.37%US$202MJun 30, 2026
Fidelity Mid Cap Index Fund708K0.37%US$220MJul 31, 2026
Invesco S&P 500 Equal Weight ETF663K0.35%US$206MJul 31, 2026
T. Rowe Price U.S. Large-Cap Core Fund, Inc.630K0.33%US$178MJun 30, 2026
Vanguard Health Care Index Fund553K0.29%US$149MMay 31, 2026
American Mutual Fund544K0.29%US$170MJul 31, 2026
T. Rowe Price Capital Appreciation Equity ETF523K0.27%US$148MJun 30, 2026
JPMorgan Mid Cap Value Fund520K0.27%US$147MJun 30, 2026
First Trust Capital Strength ETF470K0.25%US$133MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF464K0.24%US$131MJun 30, 2026
JPMorgan Growth Advantage Fund462K0.24%US$131MJun 30, 2026
Vy(R) T. Rowe Price Capital Appreciation Portfolio460K0.24%US$130MJun 30, 2026
Neuberger Quality Equity Fund459K0.24%US$124MMay 31, 2026
Old Westbury Large Cap Strategies Fund437K0.23%US$136MJul 31, 2026
Schwab S&P 500 Index Fund434K0.23%US$135MJul 31, 2026
MFS Mid Cap Value Fund423K0.22%US$120MJun 30, 2026
Invesco S&P 500 Revenue ETF414K0.22%US$112MMay 31, 2026
Bridge Builder Large Cap Growth Fund412K0.22%US$117MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund400K0.21%US$108MMay 31, 2026
T. Rowe Price All-Cap Opportunities Fund395K0.21%US$112MJun 30, 2026
Hartford Core Equity Fund389K0.20%US$121MJul 31, 2026
Heritage Fund389K0.20%US$121MJul 31, 2026
JPMorgan Value Advantage Fund371K0.19%US$105MJun 30, 2026
Fidelity Total Market Index Fund367K0.19%US$99MMay 31, 2026
Carillon Eagle Mid Cap Growth Fund335K0.18%US$94.8MJun 30, 2026
Penn Series Flexibly Managed Fund323K0.17%US$91.4MJun 30, 2026
iShares S&P 500 Value ETF320K0.17%US$90.7MJun 30, 2026

This page holds 50 of 943 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Krikorian Lazarus
Officer: SVP & Chief Accounting Officer
Sale986USD 303.18US$299KOct 1, 2026
Greenberg Lon R
Director
Sale1,280USD 321.30US$411KSep 16, 2026
Krikorian Lazarus
Officer: SVP & Chief Accounting Officer
Sale985USD 325.97US$321KSep 1, 2026
Campbell Elizabeth S
Officer: Executive Vice President
Sale11,300USD 324.12US$3.66MAug 24, 2026
Tyler Lauren M
Director
Buy550USD 270.23US$149KJun 22, 2026
Durcan Dermot Mark
Director
Buy4,000USD 274.19US$1.1MJun 18, 2026
Durcan Dermot Mark
Director
Buy4,000USD 266.26US$1.07MMay 28, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.8.50%16.4MDec 31, 2024Schedule 13G
Vanguard Capital Management LLC7.30%14.2MMar 31, 2026Schedule 13G
Walgreens Boots Alliance, Inc.4.96%9.62MJun 9, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lori J. Ryerkerk
Other companies: International Paper Company (Director · Since at least Jul 17, 2026); Norfolk Southern Corporation (Director · Since at least Jan 28, 2025); Eaton Corporation, PLC (Director · Since at least Apr 22, 2020); Celanese Corporation (Chairman and CEO, Director · May 1, 2019 – Feb 28, 2024 · Past); Axalta Coating Systems Ltd. (Director · Oct 30, 2015 – Feb 21, 2019 · Past); Hess Corporation (Senior Vice President · Nov 5, 2008 – Feb 4, 2009 · Past)
Director · Since at least Jun 1, 2025
Dermot Mark Durcan
Other companies: Veoneer Inc (VNE) (Director · Jun 12, 2018 – Apr 1, 2022 · Past); Advanced Micro Devices Inc (Director · Oct 30, 2017 – May 8, 2024 · Past); Freescale Semiconductor Ltd (Director · Aug 13, 2014 – Dec 7, 2015 · Past); MWI Veterinary Supply Inc (Director · Mar 5, 2014 – Feb 23, 2015 · Past); Micron Technology, Inc. (Chief Executive Officer, Director · Feb 13, 2006 – Oct 19, 2016 · Past)
Director · Since at least Sep 8, 2015
Frank K. Clyburn
Other companies: Kailera Therapeutics, Inc. (Director · Since at least Apr 16, 2026); Revolution Medicines, Inc. (Director · Since at least Aug 5, 2024); International Flavors & Fragrances, Inc. (Chief Executive Officer · Feb 14, 2022 – Mar 1, 2024 · Past); DuPont de Nemours, Inc. (Director · Jun 1, 2019 – Apr 28, 2021 · Past); Merck & Company, Inc. (EVP & Pres ? Human Health · Jan 1, 2019 – Oct 30, 2021 · Past)
Director · Since at least Oct 1, 2024
Gregory D Wasson
Other companies: P3 Health Partners Inc. (Director · Since at least Feb 9, 2021); OptimizeRx Corporation (Director · Since at least Jul 21, 2020); PNC Financial Services Group, Inc. (the) (Director · Jul 2, 2015 – Oct 1, 2018 · Past); Verizon Communications Inc. (Director · Mar 1, 2013 – Mar 6, 2018 · Past); Walgreen Company (President and CEO, Director · Apr 11, 2006 – Nov 12, 2014 · Past)
Director · May 15, 2014 – May 15, 2014 · Past
Kathleen W Hyle
Other companies: X-Energy, Inc. (Director · Since at least Apr 24, 2026); ADT Inc. (Director · Sep 28, 2012 – May 2, 2016 · Past); Bunge Limited (Director · Jul 2, 2012 – Mar 2, 2020 · Past); Constellation Energy Corporation (Senior Vice President · Nov 11, 2008 – Mar 12, 2012 · Past)
Director · May 13, 2010 – Mar 11, 2024 · Past
Lon R Greenberg
Other companies: Essential Utilities, Inc. (Director · Jun 1, 2012 – Sep 30, 2017 · Past); Ameriprise Financial, Inc. (Director · Apr 25, 2012 – Apr 27, 2022 · Past); AmeriGas Partners L.P (Director · Mar 21, 2012 – Dec 21, 2015 · Past); UGI Corporation (Director · Jan 1, 2012 – Jan 20, 2016 · Past)
Director · Since at least May 16, 2013
Lorence H Kim
Other companies: Revolution Medicines, Inc. (Director · Since at least Jul 12, 2022); Cowen Group Inc (Director · Feb 15, 2022 – Mar 1, 2023 · Past); Moderna, Inc. (Chief Financial Officer · Dec 7, 2018 – Jun 2, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 13, 2019 · Past)
Director · Since at least Oct 1, 2022
Eva Boratto
Other companies: Bath & Body Works, Inc. (Chief Financial Officer · Since at least Aug 1, 2023); United Parcel Service, Inc. (Director · Since at least Sep 10, 2020); CVS Health Corporation (EVP & CFO · Jul 10, 2013 – May 4, 2021 · Past)
Executive Vice President and Chief Financial Officer · Since at least Jun 29, 2026
John Palumbo
Other companies: DarioHealth Corp. (Chairman of the Board, Board Member · Since at least Apr 10, 2026); Lucid Diagnostics Inc. (Board Member · Since at least Sep 22, 2025)
Director · Apr 13, 2026 – Nov 5, 2026 · Past
Lauren M. Tyler
Other companies: Centene Corporation (Director · Since Jun 19, 2026); Alleghany Corporation (Director · Jan 15, 2019 – Oct 19, 2022 · Past)
Director · Since at least Oct 1, 2023
All 47 people
PersonSeat
Michael J Long
Other companies: Mobix Labs, Inc. (Director · Since at least Jan 22, 2024); Arrow Electronics, Inc. (Executive Chairman, Director · Dec 31, 2005 – Mar 17, 2023 · Past)
Director · May 11, 2006 – Mar 5, 2023 · Past
Richard W Gochnauer
Other companies: UGI Corporation (Director · Jan 20, 2011 – Jan 30, 2019 · Past); Essendant Inc (Chief Executive Officer, Director · Jan 1, 2009 – Mar 8, 2011 · Past)
Director · Sep 25, 2008 – Mar 11, 2024 · Past
Robert E. Sanchez
Other companies: Ryder System, Inc. (Director · Since at least Feb 7, 2020); Texas Instruments Incorporated (Director · Since at least Jan 24, 2020)
Director · Since at least Sep 25, 2026
Steven H Collis
Other companies: Bausch + Lomb Corporation (Director · Since at least Jan 1, 2026); Elevance Health, Inc. (Director · Since at least Aug 1, 2025)
Executive Chairman, Director · Since at least Feb 1, 2006
Charles H Cotros
Other companies: Allied Waste Industries Inc (Director · May 25, 2006 – Dec 5, 2008 · Past)
Director · Jan 31, 2006 – Dec 7, 2012 · Past
Dennis M Nally
Other companies: Morgan Stanley (Director · Since at least Oct 1, 2016)
Director · Since at least Jan 1, 2020
Ellen Cooper
Other companies: Lincoln National Corporation (Chairman, President & CEO, Director · Since at least Aug 6, 2012)
Director · Since at least Jan 20, 2026
Henry Wadsworth McGee III
Other companies: Tegna Inc (Director · Since at least Jun 29, 2015)
Director · Feb 1, 2006 – Mar 9, 2023 · Past
James F Cleary Jr
Other companies: MWI Veterinary Supply Inc (President and CEO, Director · Sep 26, 2008 – Feb 23, 2015 · Past)
Chief Financial Officer · Since at least Mar 5, 2015
J Lawrence Wilson
Other companies: Cummins Inc. (Director · Mar 1, 2006 – Mar 2, 2009 · Past)
Director · Feb 1, 2006 – May 1, 2009 · Past
Joy Rowan
Other companies: Merck & Company, Inc. (Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past)
Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past
Leslie Donato
Other companies: Mallinckrodt Inc (Director · Since at least Jul 31, 2025)
Director · Aug 8, 2019 – Nov 5, 2026 · Past
Pawan Verma
Other companies: Foot Locker Inc (EVP & Chief Info & Cust Conn · Aug 10, 2015 – Sep 28, 2020 · Past)
Executive Vice President and Chief Data and Information Officer · Since at least Oct 1, 2025
Peyton Howell
Other companies: Tandem Diabetes Care, Inc. (Director · Since at least Aug 3, 2020)
Executive Vice President · Feb 20, 2012 – Apr 4, 2018 · Past
Redonda Miller
Other companies: Invivyd, Inc. (Director · Nov 19, 2021 – Jun 22, 2022 · Past)
Director · Since at least Jan 1, 2023
Silvana Battaglia
Other companies: Agilon Health, Inc. (Director · Since at least Jun 22, 2023)
Executive Vice President · Since at least May 16, 2019
Sun Park
Other companies: Tenet Healthcare Corporation (Executive Vice President & Chief Financial Officer · Since at least Jan 1, 2024)
Executive Vice President · May 20, 2016 – Nov 17, 2017 · Past
Dale DanilewitzExecutive Vice President · Nov 13, 2014 – May 23, 2019 · Past
Elizabeth CampbellExecutive Vice President · Since at least Nov 8, 2023
François MandevilleExecutive Vice President and Chief Strategy and M&A Officer · Since at least Nov 5, 2026
Gina ClarkExecutive Vice President · Nov 13, 2014 – May 31, 2024 · Past
James FraryExecutive Vice President · Sep 23, 2010 – Nov 9, 2016 · Past
Jane E Md HenneyDirector · Mar 1, 2021 – Mar 5, 2023 · Past
John G ChouExecutive Vice President · Nov 11, 2015 – Dec 20, 2021 · Past
Juan GuerraExecutive Vice President, Alliance Healthcare · Since at least Nov 4, 2026
Lawrence MarshExecutive Vice President · Nov 13, 2014 – Apr 29, 2016 · Past
Lazarus KrikorianSVP & Chief Accounting Officer · Since at least Dec 5, 2014
Matt GlucksmannSVP and President, Health Systems · Since at least Nov 5, 2026
Melissa O'BrienVice President, Investor Relations · Since at least Oct 2, 2026
Michael D DicandiloExecutive VP & CFO · Jan 30, 2006 – May 2, 2011 · Past
Richard TremonteEVP and President, Global Specialty Pharmaceuticals and Operations · Since at least Nov 4, 2026
Robert P. MauchPresident and Chief Executive Officer · Since at least Nov 4, 2022
Sam HammockExecutive Vice President and Chief Human Resources Officer · Since at least Jun 15, 2026
Terrance P HaasSenior Vice President · Feb 8, 2006 – Feb 27, 2008 · Past
Tim CernohousSenior Vice President and President, Retail Pharmacy and Alternate Care · Since at least Nov 4, 2026
Tim G GuttmanChief Financial Officer · Feb 13, 2012 – Nov 9, 2018 · Past
Werner BaumannDirector · Since at least Oct 1, 2023

Open People

Log in to ask 6ix AI your own questions about Cencora, Inc.